| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/12/1999 | WO1999027916A3 Method for producing solid dosing forms |
| 08/12/1999 | WO1999027891A3 Method for producing solvent-free non-crystalline biologically active substances |
| 08/12/1999 | WO1999026606A3 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS |
| 08/12/1999 | WO1999024063A9 Compositions providing for increased igf-i solubility |
| 08/12/1999 | WO1999013864A3 Solid solution beadlet |
| 08/12/1999 | WO1999008657A3 Self-binding shearform compositions |
| 08/12/1999 | WO1999006032A3 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 08/12/1999 | WO1999002132A3 Use of submicron oil-in-water emulsions with dna vaccines |
| 08/12/1999 | WO1999002130A3 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 08/12/1999 | DE19830650C1 Dry copying to give bonded active ingredients at a substrate surface for transdermal therapy |
| 08/12/1999 | DE19804774A1 Trägermaterial für medizinische Zwecke Backing material for medical purposes |
| 08/12/1999 | DE19804604A1 Vorrichtung zur Freigabe von Stoffen Device for releasing substances |
| 08/12/1999 | DE19803453A1 Vakzine Vaccine |
| 08/12/1999 | CA2325744A1 Liposome fusion and delivery vehicle |
| 08/12/1999 | CA2320475A1 Liquid pharmaceutical formulation containing zotepine |
| 08/12/1999 | CA2319565A1 Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process |
| 08/12/1999 | CA2319468A1 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 08/12/1999 | CA2319463A1 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 08/12/1999 | CA2319353A1 Alkylene oxide polymer compositions |
| 08/12/1999 | CA2319140A1 Acid-stable and cationic-compatible cellulose compositions and methods of preparation |
| 08/12/1999 | CA2319011A1 Tablets to be crunched or sucked, comprising iron as active principle |
| 08/11/1999 | EP0934921A1 Waxes based on native raw material |
| 08/11/1999 | EP0934746A1 Substance in the form of an aqueous extract of vegetal raw material for treating oncological diseases, and method for producing the same |
| 08/11/1999 | EP0934745A1 Use of androsterone derivatives for inhibiting DNA binding of ap-1 and airway smooth muscle proliferation |
| 08/11/1999 | EP0934744A1 Nitroglycerin preparation for treatment of erectile dysfunction |
| 08/11/1999 | EP0934742A2 High glycerin containing anti-microbial cleansers |
| 08/11/1999 | EP0934593A1 Electrically conductive adhesive hydrogels |
| 08/11/1999 | EP0934353A1 Method for preparation of polymer microparticles free of organic solvent traces |
| 08/11/1999 | EP0934342A1 Composition containing chitosan |
| 08/11/1999 | EP0934093A1 System for delivery of drugs by transport |
| 08/11/1999 | EP0934082A2 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 08/11/1999 | EP0934080A2 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 08/11/1999 | EP0934079A1 Pharmaceutical composition containing lornoxicam and a disodic salt of edta |
| 08/11/1999 | EP0934078A2 Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
| 08/11/1999 | EP0934074A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract |
| 08/11/1999 | EP0934071A1 Non-aqueous colonic purgative formulations |
| 08/11/1999 | EP0934060A1 Dietary supplements |
| 08/11/1999 | EP0934059A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 08/11/1999 | EP0934058A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| 08/11/1999 | EP0934057A1 Medicinal aerosol formulations of formoterol |
| 08/11/1999 | EP0934056A1 Cleansing products |
| 08/11/1999 | EP0934053A1 Cosmetic or dermatological microemulsions |
| 08/11/1999 | EP0934041A1 Hydrogel wound dressing and the method of making and using the same |
| 08/11/1999 | EP0934040A1 Method for treating dementia due to aids |
| 08/11/1999 | EP0802779B1 Method and apparatus for producing lenticular tablets by melt calendering |
| 08/11/1999 | EP0788347B1 Stable reverse and multiple fluorocarbon emulsions |
| 08/11/1999 | EP0734249B1 Novel and improved aminoglycoside formulation for aerosolization |
| 08/11/1999 | EP0671904B1 Antibiotic formulation and use for bacterial infections |
| 08/11/1999 | EP0669127B1 Prolonged-action pharmaceutical preparation |
| 08/11/1999 | EP0663817B1 Cell encapsulating device |
| 08/11/1999 | EP0636023B1 Aminoguanidine spray drying process |
| 08/11/1999 | EP0580778B1 Convertible microemulsion formulations |
| 08/11/1999 | EP0524211B2 Pharmaceutical formulation |
| 08/11/1999 | EP0493437B2 Medicinal aerosol formulations |
| 08/11/1999 | CN2332419Y Far infrared health plaster |
| 08/11/1999 | CN2332409Y Medium containing Chinese medicine for treating hypertension |
| 08/11/1999 | CN1225591A Membrane incorporation of texaphyrins |
| 08/11/1999 | CN1225588A Non-aqueous colonic purgative formulations |
| 08/11/1999 | CN1225587A Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS |
| 08/11/1999 | CN1225583A Beta-lactam granules free of organic solvents |
| 08/11/1999 | CN1225580A Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
| 08/11/1999 | CN1225579A Granulates of hexalhydropyrazine derivatives which can be administered orally |
| 08/11/1999 | CN1225568A Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 08/11/1999 | CN1225280A Hydrogel used for repairing nerve |
| 08/11/1999 | CN1225272A Traditional Chinese medicinal injection agent for fattening and improving growth of pigs,and method for preparing same |
| 08/11/1999 | CN1225268A Clinical medicinal prepns. contg. flavongly coside extracted for persimmon leaves, and process for preparing same |
| 08/11/1999 | CN1225262A Anti cancer drug contg. taxals alcohol |
| 08/11/1999 | CN1044607C Method for preparing alginic polysaccharide sulfate |
| 08/11/1999 | CN1044564C Analgesic ointment |
| 08/11/1999 | CN1044559C Injection for curing leukemia, liver cancer and lymphoma |
| 08/10/1999 | US5935967 Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 08/10/1999 | US5935942 Co-administering a fluorescent dye encapsulated within a heat-sensitive liposome and tissue reactive agent activated by irradiation, selectively heating, monitoring, activating by irradiating |
| 08/10/1999 | US5935939 A solid state amorphous excipient for gastric antisecretory agent, antiulcer agent |
| 08/10/1999 | US5935936 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 08/10/1999 | US5935826 Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
| 08/10/1999 | US5935795 Glial cell line-derived neurotrophic factor antibody |
| 08/10/1999 | US5935610 Antacid comprising magnesium oxide, calcium carbonate and avitamine, mineral supplement for reducing stomach acidity while at the same time providing a nutritional supplement |
| 08/10/1999 | US5935604 A pulse effect, followed by controlled release and absorption of nicotine to provide a sustained high level of absorbed nicotine |
| 08/10/1999 | US5935602 Dosage forms of risedronate |
| 08/10/1999 | US5935601 Acylated peptide as a carrier for oral administration |
| 08/10/1999 | US5935600 Process for forming chewable quickly dispersing comestible unit and product therefrom |
| 08/10/1999 | US5935599 Polymer-associated liposomes for drug delivery and method of manufacturing the same |
| 08/10/1999 | US5935598 Iontophoretic delivery of cell adhesion inhibitors |
| 08/10/1999 | US5935597 A transdermal reservoir containing a polar compound such as dimethylformamide or dimethylsulfoxide |
| 08/10/1999 | US5935596 Delivery of skin benefit agents via adhesive strips |
| 08/10/1999 | US5935593 Chemo-mechanical expansion delivery system |
| 08/10/1999 | US5935592 Method for treating vaginitis and endometriosis |
| 08/10/1999 | US5935588 Includes polyol; cleaning compounds and protectants for hair, skin, and mucous membranes |
| 08/10/1999 | US5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin |
| 08/10/1999 | US5935566 Stable aqueous alfa interferon solution formulations |
| 08/10/1999 | US5935559 Silicone composition containing a water-sensitive active agent |
| 08/10/1999 | US5935555 Pharmaceutical formulations for treating cystic fibrosis |
| 08/10/1999 | US5935553 Methods of preparing gas-filled liposomes |
| 08/10/1999 | US5934273 Administration of drugs by means of a dry powder inhaler which enhances efficient delivery to the lungs, prevents deposition in mouth and throat |
| 08/10/1999 | CA2236110A1 Poultice |
| 08/10/1999 | CA2201264C Immediate release ph-independent solid dosage form of cisapride |
| 08/10/1999 | CA2161632C Seal configuration for aerosol canister |
| 08/10/1999 | CA2131647C Sustained release heterodisperse hydrogel systems for insoluble drugs |
| 08/09/1999 | WO1999039680A1 Antifungal nail lacquer and method using same |
| 08/05/1999 | WO1999039045A1 Aqueous compositions comprising complexing agents and uses therof |